Related Experiment Video
Updated: Aug 4, 2026
13:36
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays
L W Whitney1, K G Becker, N J Tresser
1Molecular Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1400, USA.
Annals of Neurology
|September 11, 1999
Summary
Researchers identified 62 differentially expressed genes in multiple sclerosis (MS) brain lesions using cDNA microarray technology. This powerful tool helps uncover new genes involved in MS pathology, advancing our understanding of the disease.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Genetics
Background:
- Multiple sclerosis (MS) involves immune system attacks on oligodendrocytes and myelin, causing brain and spinal cord lesions.
- The genetic factors contributing to MS lesion pathology are not fully understood, with limited genes identified to date.
Purpose of the Study:
- To identify novel genes associated with multiple sclerosis (MS) lesion pathology.
- To explore the utility of cDNA microarray technology in discovering new MS-related genes.
Main Methods:
- Gene expression profiling of normal white matter versus acute MS brain lesions.
- Utilized cDNA microarray technology to analyze over 5,000 genes.
- Compared gene expression patterns between healthy and MS affected tissue.
Main Results:
- Identified 62 differentially expressed genes between normal white matter and MS lesions.
- Notable genes identified include Duffy chemokine receptor, interferon regulatory factor-2, and tumor necrosis factor alpha receptor-2.
- Demonstrated significant differences in gene expression profiles in MS lesions.
Conclusions:
- cDNA microarray technology is a powerful tool for identifying genes previously unassociated with MS.
- The identified genes offer potential new targets for understanding and treating MS.
- This study expands the known genetic landscape of multiple sclerosis pathology.
